Zacks Research Issues Positive Forecast for EMN Earnings

Eastman Chemical Company (NYSE:EMN) – Equities research analysts at Zacks Research increased their Q3 2026 EPS estimates for shares of Eastman Chemical in a research report issued to clients and investors on Thursday, August 13th. Zacks Research analyst Team now expects that the basic materials company will post earnings of $1.95 per share for the quarter, up from their previous estimate of $1.69. The consensus estimate for Eastman Chemical’s current full-year earnings is $6.43 per share. Zacks Research also issued estimates for Eastman Chemical’s Q4 2026 earnings at $1.38 EPS, Q1 2027 earnings at $1.61 EPS, Q2 2027 earnings at $1.73 EPS, Q3 2027 earnings at $1.77 EPS, Q4 2027 earnings at $1.65 EPS, FY2027 earnings at $6.76 EPS, Q1 2028 earnings at $1.55 EPS, Q2 2028 earnings at $1.78 EPS and FY2028 earnings at $6.93 EPS.

EMN has been the topic of a number of other research reports. Deutsche Bank Aktiengesellschaft reissued a “hold” rating and set a $74.00 price target on shares of Eastman Chemical in a research note on Monday, August 3rd. Wells Fargo & Company upped their price objective on shares of Eastman Chemical from $70.00 to $80.00 and gave the company an “equal weight” rating in a research note on Monday, May 4th. Wall Street Zen raised shares of Eastman Chemical from a “hold” rating to a “buy” rating in a research report on Saturday, August 1st. Royal Bank Of Canada boosted their target price on shares of Eastman Chemical from $69.00 to $74.00 and gave the company a “sector perform” rating in a report on Wednesday, August 5th. Finally, Citigroup cut their price target on shares of Eastman Chemical from $85.00 to $81.00 and set a “buy” rating on the stock in a research note on Monday, August 3rd. Seven research analysts have rated the stock with a Buy rating and seven have given a Hold rating to the company. Based on data from MarketBeat.com, the company has a consensus rating of “Moderate Buy” and an average target price of $79.17.

Eastman Chemical Stock Up 1.7%

EMN stock opened at $73.76 on Friday. The company has a 50 day moving average price of $70.41 and a two-hundred day moving average price of $72.49. The company has a debt-to-equity ratio of 0.72, a quick ratio of 0.76 and a current ratio of 1.50. The stock has a market capitalization of $8.44 billion, a P/E ratio of 19.21, a PEG ratio of 0.90 and a beta of 1.06. Eastman Chemical has a one year low of $56.11 and a one year high of $83.47.

Eastman Chemical (NYSE:EMN) last released its quarterly earnings results on Thursday, July 30th. The basic materials company reported $1.97 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.82 by $0.15. The company had revenue of $2.51 billion for the quarter, compared to analysts’ expectations of $2.40 billion. Eastman Chemical had a net margin of 4.99% and a return on equity of 9.46%. The firm’s revenue for the quarter was up 9.9% compared to the same quarter last year. During the same period last year, the company earned $1.60 EPS. Eastman Chemical has set its Q3 2026 guidance at 1.970-1.970 EPS.

Institutional Trading of Eastman Chemical

Several large investors have recently added to or reduced their stakes in EMN. Lido Advisors LLC raised its stake in shares of Eastman Chemical by 0.6% during the fourth quarter. Lido Advisors LLC now owns 20,313 shares of the basic materials company’s stock valued at $1,297,000 after purchasing an additional 125 shares during the period. Altshuler Shaham Ltd lifted its position in shares of Eastman Chemical by 36.9% during the first quarter. Altshuler Shaham Ltd now owns 538 shares of the basic materials company’s stock worth $41,000 after purchasing an additional 145 shares during the last quarter. Generali Asset Management SPA SGR lifted its position in shares of Eastman Chemical by 9.6% during the fourth quarter. Generali Asset Management SPA SGR now owns 1,700 shares of the basic materials company’s stock worth $109,000 after purchasing an additional 149 shares during the last quarter. UMB Bank n.a. grew its stake in Eastman Chemical by 6.2% in the fourth quarter. UMB Bank n.a. now owns 2,571 shares of the basic materials company’s stock worth $164,000 after purchasing an additional 150 shares in the last quarter. Finally, D.A. Davidson & CO. increased its holdings in Eastman Chemical by 0.7% in the second quarter. D.A. Davidson & CO. now owns 20,743 shares of the basic materials company’s stock valued at $1,389,000 after buying an additional 153 shares during the last quarter. 83.65% of the stock is currently owned by institutional investors and hedge funds.

Eastman Chemical Announces Dividend

The firm also recently declared a quarterly dividend, which will be paid on Wednesday, October 7th. Investors of record on Tuesday, September 15th will be issued a $0.84 dividend. The ex-dividend date is Tuesday, September 15th. This represents a $3.36 annualized dividend and a yield of 4.6%. Eastman Chemical’s dividend payout ratio (DPR) is presently 87.50%.

Key Stories Impacting Eastman Chemical

Here are the key news stories impacting Eastman Chemical this week:

• Positive Sentiment: Zacks raised its Q3 2026 EPS estimate to $1.95 from $1.69, a significant improvement that could indicate stronger-than-expected near-term operating performance. Eastman Chemical analyst estimate report
• Positive Sentiment: Estimates were also increased for Q4 2026 to $1.38 from $1.33, Q1 2027 to $1.61 from $1.52, Q2 2027 to $1.73 from $1.69, and Q3 2027 to $1.77 from $1.70.
• Positive Sentiment: Zacks lifted its FY2027 EPS forecast to $6.76 from $6.59, which is above the current full-year consensus estimate of $6.43 and may strengthen the earnings-growth case for EMN.
• Positive Sentiment: The separate Zacks value-stock commentary identifies Eastman Chemical as an attractive value candidate, potentially supporting investor interest given its $8.44 billion market capitalization and price-to-earnings ratio near 19. Here’s Why Eastman Chemical is a Strong Value Stock
• Neutral Sentiment: FY2028 EPS remains forecast at $6.93, but the estimate is below the prior $7.09 forecast, indicating longer-term expectations have softened despite the FY2027 upgrade.
• Negative Sentiment: Zacks reduced Q4 2027 EPS to $1.65 from $1.67 and Q2 2028 EPS to $1.78 from $1.84, modest downgrades that temper the otherwise positive revision trend.

About Eastman Chemical

Eastman Chemical Company (NYSE: EMN) is a global specialty materials company that develops, manufactures and markets a broad range of advanced materials, chemicals and fibers. Its product portfolio spans performance additives, functional products, and engineered plastics designed to enhance the durability, appearance and performance of end products across diverse industries.

The company’s main business activities include the production of specialty chemicals used in adhesives, coatings, building materials and consumer care applications, as well as high-performance plastics for packaging, automotive and electronics markets.